These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11471900)

  • 1. Serum tumor markers: past, state of the art, and future.
    Thomas CM; Sweep CG
    Int J Biol Markers; 2001; 16(2):73-86. PubMed ID: 11471900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum tumor markers in chronic kidney disease: as clinical tool in diagnosis, treatment and prognosis of cancers.
    Amiri FS
    Ren Fail; 2016; 38(4):530-44. PubMed ID: 26907957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibody biomarkers in the detection of cancer.
    Cho-Chung YS
    Biochim Biophys Acta; 2006 Jun; 1762(6):587-91. PubMed ID: 16730166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When and how to use serum tumor markers in clinical practice.
    Markman M
    Cleve Clin J Med; 1997 Jan; 64(1):27-9. PubMed ID: 9014381
    [No Abstract]   [Full Text] [Related]  

  • 5. Determination of tumor markers in serum. Pitfalls and good practice.
    Basuyau JP; Leroy M; Brunelle P
    Clin Chem Lab Med; 2001 Dec; 39(12):1227-33. PubMed ID: 11798082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical usefulness of circulating tumor markers].
    Ohkura H
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1131-4. PubMed ID: 15272600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour markers in the years to come; challenges, possibilities and goals.
    Vockel A
    Scand J Clin Lab Invest Suppl; 1991; 206():102-5. PubMed ID: 1947755
    [No Abstract]   [Full Text] [Related]  

  • 8. Predictive biomarkers in clinical practice: State of the art and perspectives in solid tumors.
    Ulivi P
    Int J Biol Markers; 2020 Feb; 35(1_suppl):16-19. PubMed ID: 32079460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Search for serum tumor markers continues.
    McIntosh H
    J Natl Cancer Inst; 1992 Mar; 84(6):387-9. PubMed ID: 1538415
    [No Abstract]   [Full Text] [Related]  

  • 10. [The future of molecular markers in cancer: towards a tailored treatment].
    Gascón P
    Med Clin (Barc); 2009 Apr; 132(14):549-50. PubMed ID: 19368936
    [No Abstract]   [Full Text] [Related]  

  • 11. Autoantibody biomarker opens a new gateway for cancer diagnosis.
    Nesterova M; Johnson N; Cheadle C; Cho-Chung YS
    Biochim Biophys Acta; 2006 Apr; 1762(4):398-403. PubMed ID: 16483750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumor markers: a guide to their appropriate clinical use | Comparative summary of recommendations from clinical practice guidelines (PART 3).
    Gion M; Trevisiol C; Rutjes AWS; Rainato G; Fabricio ASC
    Int J Biol Markers; 2017 May; 32(2):e147-e181. PubMed ID: 28475208
    [No Abstract]   [Full Text] [Related]  

  • 13. Circulating tumor markers: a guide to their appropriate clinical use | Comparative summary of recommendations from clinical practice guidelines (PART 2).
    Gion M; Trevisiol C; Rutjes AWS; Rainato G; Fabricio ASC
    Int J Biol Markers; 2017 Mar; 32(1):e1-e52. PubMed ID: 28255982
    [No Abstract]   [Full Text] [Related]  

  • 14. Systemic mirnas as potential biomarkers for malignancy.
    Healy NA; Heneghan HM; Miller N; Osborne CK; Schiff R; Kerin MJ
    Int J Cancer; 2012 Nov; 131(10):2215-22. PubMed ID: 22618667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum tumour markers in asymptomatic patients].
    Torné Cachot J; Baucells Azcona JM; Blanch Falp J; Blancas Altabella D
    Med Clin (Barc); 2015 Oct; 145(7):319-20. PubMed ID: 25978922
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinically Meaningful Use of Blood Tumor Markers in Oncology.
    Holdenrieder S; Pagliaro L; Morgenstern D; Dayyani F
    Biomed Res Int; 2016; 2016():9795269. PubMed ID: 28042579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of tumour markers in ascitic fluid and serum: are measurements of ascitic tumour markers a futile attempt?
    Tuzun Y; Celik Y; Bayan K; Yilmaz S; Dursun M; Canoruc F
    J Int Med Res; 2009; 37(1):79-86. PubMed ID: 19215676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies.
    Larrea E; Sole C; Manterola L; Goicoechea I; Armesto M; Arestin M; Caffarel MM; Araujo AM; Araiz M; Fernandez-Mercado M; Lawrie CH
    Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use and potential of serum tumour markers, new and old.
    Bates SE
    Drugs; 1989 Jul; 38(1):9-18. PubMed ID: 2670513
    [No Abstract]   [Full Text] [Related]  

  • 20. Review of Commonly Used Serum Tumor Markers and Their Relevance for Image Interpretation.
    Reiter MJ; Costello JE; Schwope RB; Lisanti CJ; Osswald MB
    J Comput Assist Tomogr; 2015; 39(6):825-34. PubMed ID: 26248153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.